Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BY 4.0Animal Cells and Systems

OGS-MA114 ameliorates FUS mutant-associated ALS pathology by activating PINK1-dependent mitophagy

4 affiliations
  1. 1School of Life Sciences, BK21 FOUR KNU Creative BioResearch Group, Kyungpook National University, Daegu, Republic of Korea
  2. 2Zebrafish Translational Medical Research Center, Department of Biomedical Sciences, Korea University, Ansan, Republic of Korea
  3. 3Organelle Institute, Kyungpook National University, Daegu, Republic of Korea
  4. 4ORGASIS Corp., Suwon, Republic of Korea

Abstract

Mitochondrial dysfunction and impaired mitophagy are increasingly recognized as central contributors to pathogenesis of amyotrophic lateral sclerosis (ALS). In this study, we identified OGS-MA114 (C₂₃H₁₉ClN₄O₃S), as a compound that activates mitophagy through a bioactive chemical library screen in SH-SY5Y cells. OGS-MA114 significantly enhanced autophagic and mitophagic flux, increased Ser65-phosphorylated ubiquitin levels, and promoted Parkin recruitment to damaged mitochondria, indicating activation of the PINK1/Parkin pathway. In SH-SY5Y cells expressing the ALS-associated FUSP525L mutant, OGS-MA114 restored mitochondrial membrane potential, reduced cleaved caspase-3 levels, and improved cell viability under mitochondrial stress conditions. Furthermore, in a transgenic zebrafish model expressing mutant FUSR521C, OGS-MA114 significantly improved locomotor activity and survival while reducing cell death in the spinal cord. These findings suggest that OGS-MA114 ameliorates ALS-associated pathological phenotypes by enhancing PINK1-dependent mitophagy. Thus, pharmacological modulation of mitophagy may provide a useful basis for further investigation of ALS and -related neurodegenerative disorders.

Related

  1. 40 Hz vibrotactile stimulation ameliorates amyloid pathology and cognitive deficits in 5xFAD mice and is associated with alterations in Piezo1, ERK, and GSK-3β/p65 signaling
    Myeong-Hyun Nam, Hee-Jung Park, Hee-Yeon Lee +7
    NeurotherapeuticsPeer-reviewedCC BYFull textPhysiologyDOAJ
  2. Lactylation-driven mitochondrial dysfunction promotes diabetic myocardial fibrosis via impairing mitophagy and activating TGF-β1
    Bing Lian, Junyan Li, Yonglong Guo +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textCardiovascular medicineCrossref
  3. Mild heat treatment ameliorates PCOS by activating PI3K/Akt signaling and inhibiting granulosa cell apoptosis
    Zhe Yang, Qixuan Zhang, Xiangyang Ou +6
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textObstetrics, gynaecology & paediatricsCrossref
  4. Sanguinarine ameliorates rheumatoid arthritis by activating the Hippo-YAP/TAZ pathway to induce apoptosis and suppress inflammation in fibroblast-like synoviocytes
    Jun Cai, Yong-Gu Cai, Jing-Yi Luo +3
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  5. Clemastine alleviates Parkinson’s disease pathology by activating the AMPK/mTOR pathway and enhancing autophagic flux
    Ting Fan, Caihui Wei, Wenzhi Chen +4
    Frontiers in aging neurosciencePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{kim2026ogsma114,
  title = {{OGS-MA114 ameliorates FUS mutant-associated ALS pathology by activating PINK1-dependent mitophagy}},
  author = {Seong Hyun Kim and Jun Hee So and Yunkyoung Lee and Na Yeon Park and Jung Sang Park and Pansoo Kim and Ji-Eun Bae and Doo Sin Jo and Hae-Chul Park and Dong-Hyung Cho},
  journal = {Animal Cells and Systems},
  year = {2026},
  month = nov,
  doi = {10.1080/19768354.2026.2736980},
  url = {https://doi.org/10.1080/19768354.2026.2736980},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - OGS-MA114 ameliorates FUS mutant-associated ALS pathology by activating PINK1-dependent mitophagy
AU  - Seong Hyun Kim
AU  - Jun Hee So
AU  - Yunkyoung Lee
AU  - Na Yeon Park
AU  - Jung Sang Park
AU  - Pansoo Kim
AU  - Ji-Eun Bae
AU  - Doo Sin Jo
AU  - Hae-Chul Park
AU  - Dong-Hyung Cho
PY  - 2026
DA  - 2026/11/10
JO  - Animal Cells and Systems
DO  - 10.1080/19768354.2026.2736980
UR  - https://doi.org/10.1080/19768354.2026.2736980
AB  - Mitochondrial dysfunction and impaired mitophagy are increasingly recognized as central contributors to pathogenesis of amyotrophic lateral sclerosis (ALS). In this study, we identified OGS-MA114 (C₂₃H₁₉ClN₄O₃S), as a compound that activates mitophagy through a bioactive chemical library screen in SH-SY5Y cells. OGS-MA114 significantly enhanced autophagic and mitophagic flux, increased Ser65-phosphorylated ubiquitin levels, and promoted Parkin recruitment to damaged mitochondria, indicating activation of the PINK1/Parkin pathway. In SH-SY5Y cells expressing the ALS-associated FUSP525L mutant, OGS-MA114 restored mitochondrial membrane potential, reduced cleaved caspase-3 levels, and improved cell viability under mitochondrial stress conditions. Furthermore, in a transgenic zebrafish model expressing mutant FUSR521C, OGS-MA114 significantly improved locomotor activity and survival while reducing cell death in the spinal cord. These findings suggest that OGS-MA114 ameliorates ALS-associated pathological phenotypes by enhancing PINK1-dependent mitophagy. Thus, pharmacological modulation of mitophagy may provide a useful basis for further investigation of ALS and -related neurodegenerative disorders.
SN  - 1976-8354
SN  - 2151-2485
ER  -